Dmitry Balyasny Balyasny Asset Management
Dmitry Balyasny is the founder of Balyasny Asset Management, a major multi-strategy and multi-manager hedge fund platform. The firm allocates capital across fundamental equities, macro, quant, and other teams under a central risk framework. Balyasny’s platform is often cited alongside other leading pod-shop multi-strategy firms.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SPCX
SpaceX
SPCX
|
+$577M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$538M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$517M |
| 4 |
Texas Instruments
TXN
|
+$413M |
| 5 |
Roku
ROKU
|
+$356M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HOLX
Hologic
HOLX
|
+$357M |
| 2 |
Meta Platforms (Facebook)
META
|
+$326M |
| 3 |
Johnson Controls International
JCI
|
+$303M |
| 4 |
Applied Materials
AMAT
|
+$285M |
| 5 |
CTRA
Coterra Energy
CTRA
|
+$285M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.69% |
| 2 | Industrials | 9.96% |
| 3 | Consumer Discretionary | 8.03% |
| 4 | Healthcare | 7.46% |
| 5 | Financials | 6.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2801
PennantPark Floating Rate Capital
PFLT
$731M
| $82.5K | ﹤0.01% |
+11,025
| New | +$91.6K |
|
2802
Fortive
FTV
$18.1B
| $76.9K | ﹤0.01% |
1,258
-3,981
| -76% | -$239K |
|
|
TSI
2803
TCW Strategic Income Fund
TSI
$278M
| $76.6K | ﹤0.01% |
16,994
-74,312
| -81% | -$337K |
|
2804
RPC Inc
RES
$1.41B
| $76.3K | ﹤0.01% |
13,084
-230,546
| -95% | -$1.61M |
|
2805
Stem
STEM
$54.9M
| $75.9K | ﹤0.01% |
+9,717
| New | +$90.1K |
|
2806
Wipro
WIT
$18.7B
| $75.9K | ﹤0.01% |
33,727
-11,774
| -26% | -$25K |
|
2807
Coty
COTY
$2.41B
| $74.3K | ﹤0.01% |
34,382
-4,138,660
| -99% | -$8.93M |
|
2808
ASP Isotopes
ASPI
$613M
| $72.4K | ﹤0.01% |
11,636
-64,885
| -85% | -$382K |
|
2809
Expensify
EXFY
$241M
| $66.9K | ﹤0.01% |
37,387
-12,593
| -25% | -$14.1K |
|
|
GME.WS
2810
GameStop Corp Warrants
GME.WS
| $65.8K | ﹤0.01% |
23,576
+100
| +0.4% | +$338 |
|
2811
Arvinas
ARVN
$613M
| $52.1K | ﹤0.01% |
+6,273
| New | +$58.5K |
|
2812
Larimar Therapeutics
LRMR
$434M
| $51.9K | ﹤0.01% |
+17,006
| New | +$67.5K |
|
2813
Ardagh Metal Packaging
AMBP
$3.2B
| $51.6K | ﹤0.01% |
+10,893
| New | +$44.7K |
|
|
XRXDW
2814
Xerox Holdings Corp Warrants
XRXDW
$22.8M
| $47K | ﹤0.01% |
171,069
| – | – |
|
|
LMRI
2815
Lumexa Imaging Holdings
LMRI
$1.19B
| $46.8K | ﹤0.01% |
+4,152
| New | +$37.9K |
|
2816
UWM Holdings
UWMC
$2.25B
| $45K | ﹤0.01% |
+19,630
| New | +$61K |
|
2817
Valens Semiconductor
VLN
$196M
| $44.8K | ﹤0.01% |
+19,808
| New | +$44.4K |
|
2818
Phillips 66
PSX
$96.9B
| $40.4K | ﹤0.01% |
239
-14,836
| -98% | -$2.55M |
|
|
CIRC
2819
Circle8 Group
CIRC
$57M
| $40.2K | ﹤0.01% |
+43,737
| New | +$69K |
|
2820
Automatic Data Processing
ADP
$112B
| $39.6K | ﹤0.01% |
177
-11,843
| -99% | -$2.53M |
|
2821
Ribbon Communications
RBBN
$363M
| $38.1K | ﹤0.01% |
+16,288
| New | +$43K |
|
2822
MasTec
MTZ
$21.4B
| $37.9K | ﹤0.01% |
91
-128,537
| -100% | -$49.1M |
|
|
OPENW
2823
Opendoor Technologies Inc Series K Warrants
OPENW
$6.46M
| $37.3K | ﹤0.01% |
75,409
| – | – |
|
2824
Microvast
MVST
$309M
| $37.3K | ﹤0.01% |
+31,838
| New | +$49.1K |
|
2825
Fate Therapeutics
FATE
$279M
| $36.2K | ﹤0.01% |
+13,413
| New | +$24.8K |
|
Similar funds
Dmitry Balyasny's Q2 2026 Portfolio in Review
As of Q2 2026, Dmitry Balyasny held 3,665 positions worth $80.2B, up 4% from $77.1B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Dmitry Balyasny withdrew a net $7.14B in Q2 2026, closing 734 positions and reducing 995 holdings. Its most notable exit was Hologic, an estimated $357M position sold in full.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 9.7% a quarter earlier, followed by Industrials and Consumer Discretionary.
Against the trend, Dmitry Balyasny opened a new position in SpaceX worth $581M.
- Dmitry Balyasny's largest Q2 2026 buy was SpaceX: 3,397,642 shares worth $581M.
- Dmitry Balyasny added most to State Street SPDR S&P 500 ETF Trust in Q2 2026, an estimated $538M increase.
- Dmitry Balyasny's biggest Q2 2026 reduction was Meta Platforms (Facebook), cutting an estimated $326M.
- Dmitry Balyasny fully exited Hologic in Q2 2026, selling an estimated $357M.
- Dmitry Balyasny's ten largest holdings make up 14% of its $80.2B portfolio in Q2 2026.
- Dmitry Balyasny opened 834 new positions and closed 734 in Q2 2026.
- Dmitry Balyasny's portfolio value rose 4% quarter-over-quarter to $80.2B.
Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.